Sonoma Pharmaceuticals (SNOA) Tax Provisions (2016 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Tax Provisions of -$130000.0 in Q4 2025, up 34.01% quarter-over-quarter from -$197000.0 in Q3 2025, and down 1544.44% on a YoY basis from $9000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Tax Provisions (2016 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Tax Provisions history runs 8 years deep, the most recent figure standing at -$130000.0 for Q4 2025.
- In Q4 2025, Tax Provisions fell 1544.44% year-over-year to -$130000.0; the TTM figure through Dec 2025 stood at -$80000.0 (down 900.0% YoY), while the FY2025 annual figure was $550000.0, up 380.61% from the prior year.
- Tax Provisions was -$130000.0 for Q4 2025 at Sonoma Pharmaceuticals, up from -$197000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $713000.0 in Q1 2021 to a low of -$292000.0 in Q1 2024.
- Historically, Tax Provisions has averaged $65722.2 across 5 years, with a median of $7000.0 in 2021.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions jumped 1900.0% in 2022, then plunged 1544.44% in 2025.
- A 5-year view of Tax Provisions shows it stood at $5000.0 in 2021, then jumped by 580.0% to $34000.0 in 2022, then plunged by 267.65% to -$57000.0 in 2023, then surged by 115.79% to $9000.0 in 2024, then slumped by 1544.44% to -$130000.0 in 2025.
- The last three Tax Provisions figures came in at -$130000.0 (Q4 2025), -$197000.0 (Q3 2025), and -$1000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 67.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 157.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -3.57 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 48.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 30.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.60 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -9.44 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 37.99 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | -130,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -130,000.00 |
| Sep 30, 2025 | -197,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | 248,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Mar 31, 2024 | -292,000.00 |
| Dec 31, 2023 | -57,000.00 |
| Sep 30, 2023 | 186,000.00 |
| Jun 30, 2023 | -33,000.00 |
| Mar 31, 2023 | -131,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | -35,000.00 |
| Mar 31, 2022 | 471,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 713,000.00 |
| Mar 31, 2018 | 50,000.00 |
| Mar 31, 2017 | 4.05 Mn |